The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Oct. 02, 2018
Applicant:

Ablynx N.v., Ghent-Zwijnaarde, BE;

Inventors:

Josefin-Beate Holz, Munich, DE;

Stefaan Rossenu, Lovendegem, BE;

Steven De Bruyn, Baal, BE;

Maria-Laura Sargentini-Maier, Brussels, BE;

Özkan Yalkinoglu, Wuppertal, DE;

Assignee:

Ablynx N.V., Zwijnaarde, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 14/54 (2006.01); C07K 14/715 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); C07K 14/5412 (2013.01); C07K 14/7155 (2013.01); C07K 2317/22 (2013.01); C07K 2317/569 (2013.01);
Abstract

Polypeptides are provided directed against IL-6R at specific dose ranges and dosing schedules that result in a prolonged effect on IL-6 mediated signaling. In particular, the invention provides pharmacologically active agents, compositions, methods and/or dosing schedules that have certain advantages compared to the agents, compositions, methods and/or dosing schedules that are currently used and/or known in the art, including the ability to dose less frequently or to administer lower doses to obtain equivalent effects in inhibiting IL-6 mediated signaling.


Find Patent Forward Citations

Loading…